
Praxis Precision Medicines has delivered a very large 3 year share price gain, yet recent pullbacks and a shifting business profile now put the spotlight on a more basic question.…
PRAX is up 5.70% today. Volume is 355.4K vs a 30-day average of 552.4K (0.64x).
Praxis Precision Medicines, Inc is scheduled to report earnings Wed, Nov 11, 2026. Analysts expect EPS of $-3.86. Stocks often move sharply on earnings day.

Praxis Precision Medicines has delivered a very large 3 year share price gain, yet recent pullbacks and a shifting business profile now put the spotlight on a more basic question.…
JP Morgan analyst Tessa Romero initiates coverage on Praxis Precision Medicine (NASDAQ:PRAX) with a Overweight rating and announces Price Target of $700.
HC Wainwright & Co. analyst Douglas Tsao reiterates Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and maintains $1201 price target.